Results 221 to 230 of about 276,897 (341)
Directed evolution-driven reprogramming of PD-L1 for compact and tunable checkpoint modulation. [PDF]
Ha JY +6 more
europepmc +1 more source
Pneumatically‐Actuated Liquid Metal‐Based Frequency Reconfigurable Antenna
A look at a flexible, frequency‐tuning antenna A Soft Solution: Introducing a new antenna design made with liquid metal composites. A Full Package: Combining flexible antennas with pneumatic actuators. End‐to‐End Control: Automatic reconfiguration according to signal strength.
Yiwen Song +6 more
wiley +1 more source
Phospholipid transfer protein(PLTP) plays a critical role in forming a complex with kinase A (AURKA) and P65. This interaction facilitates phosphorylation of P65 at Ser536, leading to the activation of the NF‐κB signaling pathway. Ultimately, this leads to the upregulation of downstream cytokines, including IL‐6, IL‐8, and CSF‐1, which promotes M2 ...
Xinyue Liang +14 more
wiley +1 more source
PD-L1 expression and soluble PD-L1 production in gastric cancer
研究科: 千葉大学大学院医学薬学府(先端医学薬学専攻) 学位記番号 ...
openaire
Extracellular vesicles (EVs) released from TGF‐β‐activated CAFs are enriched with ECM proteins such as TSG6 and THBS1, which facilitate their binding to recipient cell membranes. This EV–cell interaction promotes the clustering of CD44 and TGF‐β receptors on the target cell surface, thereby potentiating TGF‐β signaling activity. This study highlights a
Chao Li +7 more
wiley +1 more source
Peripheral blood biomarkers for predicting response to PD-1/PD-L1 inhibitors. [PDF]
Chen S +5 more
europepmc +1 more source
Functional, Pharmacogenomic, and Immune Landscapes of Long Non‐Coding RNAs in Cancer
A systematic analysis of 33 cancer types reveals widespread associations between lncRNAs and cancer pathways, drug responses, immune features, and immunotherapy outcomes. The study identifies key lncRNAs linked to therapeutic response and adverse events and introduces PILNC, an interactive web portal for exploring the functional, pharmacogenomic, and ...
Runhao Wang +15 more
wiley +1 more source
Immunotherapy for Glioblastoma: A Focus on PD-1/PD-L1 Inhibitors. [PDF]
Zoi V +4 more
europepmc +1 more source

